Vendis Capital has invested in the Nederlandse Obesitas Kliniek, a leading medical weight loss clinic in the Netherlands, to accelerate its growth and expand innovative obesity treatments.
Information on the Target
Vendis Capital, a European private equity fund specializing in the consumer sector, has announced its investment in the Nederlandse Obesitas Kliniek (NOK), the foremost medical weight loss clinic in the Netherlands. Established in 1993 and headquartered in Huis ter Heide, NOK provides a comprehensive range of weight loss treatments, including lifestyle interventions, bariatric surgery, and GLP-1 therapy.
With more than 30 years of experience, NOK has become synonymous with effective obesity treatment in the Netherlands. It operates 11 clinics nationwide and collaborates with 7 leading clinical hospitals, earning recognition for delivering exceptional long-term weight loss outcomes. The clinic employs a holistic, multidisciplinary approach, where patients receive support from a diverse team of medical professionals, psychologists, nutritionists, physiotherapists, and lifestyle coaches. NOK has successfully completed over 50,000 treatments, with more than 9,000 new patients treated in just the past year.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The healthcare industry in the Netherlands is characterized by its progressive policies and commitment to patient-centered care. Weight management and obesity treatment have emerged as critical focus areas, with the Dut
Similar Deals
819 Capital Partners → Smart Industry TTT and Medtech TTT funds
2025
European Dental Group → Fresh Tandartsen
2025
Vendis Capital → Prime Care Clinics
2025
Holland Capital → Medexs and Van Vliet Healthcare
2025
Danone → The Akkermansia Company
2025
Vendis Capital
invested in
Nederlandse Obesitas Kliniek
in 2024
in a Other Private Equity deal